10th Edition of
World Congress on Infectious Diseases & One Health
October 05-07, 2026 | Tokyo, Japan
In the realm of antimicrobials, Broad Spectrum Antibiotics stand out as versatile weapons against a wide array of bacterial threats. These antibiotics are adept at tackling infections caused by bacteria with varying cell wall structures, making them invaluable in medical practice. Tetracycline is an exemplary broad-spectrum antibiotic, renowned for its ability to combat a broad spectrum of bacteria. Tetracycline acts by inhibiting bacterial protein synthesis, thereby impeding the growth and propagation of a diverse range of bacteria. Its effectiveness against both Gram-positive and Gram-negative organisms positions it as a reliable choice for treating respiratory infections, skin conditions, and sexually transmitted diseases. Broad Spectrum Antibiotics like Tetracycline exemplify the ongoing commitment to developing antimicrobial solutions that address the dynamic and diverse nature of bacterial infections.
Title : Molecular crosstalk between the host and pathogen in Streptococcus pyogenes virulence
Francis J Castellino, University of Notre Dame, United States
Title : Phenotypic characterisation of non tuberculous mycobacterium species isolated from clinical specimens
Anant Marathe, Parul Institute of Medical Sciences and Research, Parul University, India
Title : An unprecedented West Nile virus outbreak in Israel (2024): A textbook case for the One Health approach
Michel Bellaiche, Kimron Veterinary Institute, Israel
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, IDFISH Technology, United States
Title : Candida auris infections are global health challenge
Reza Nassiri, Michigan State University, United States
Title : Host brakes on viral inflammation
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States